UNICREDIT BANK/CALL/FRESENIUS/34/1/18.09.24 Share Price

Warrant

DE000HD5DAE2

Market Closed - BOERSE MUENCHEN 20:42:01 05/07/2024 BST
0.22 EUR +29.41% Intraday chart for UNICREDIT BANK/CALL/FRESENIUS/34/1/18.09.24
Current month+69.23%
1 month-50.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/07/24 0.22 +29.41%
04/07/24 0.17 +41.67%
03/07/24 0.12 +9.09%
02/07/24 0.11 -15.38%
01/07/24 0.13 0.00%

Real-time BOERSE MUENCHEN

Last update July 05, 2024 at 08:42 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer UniCredit UniCredit
WKN HD5DAE
ISINDE000HD5DAE2
Date issued 08/05/2024
Strike 34
Maturity 18/09/2024 (73 Days)
Parity 1 : 1
Emission price 0.6
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.65
Lowest since issue 0.11
Delta0.12x
Omega 17.88
Premium17.51x
Gearing149.23x
Moneyness 0.8559
Difference Strike 4.9
Difference Strike %+14.41%
Spread 0.05
Spread %22.73%
Theoretical value 0.1950
Implied Volatility 26.44 %
Total Loss Probability 90.27 %
Intrinsic value 0.000000
Present value 0.1950
Break even 34.20 €
Theta-0.03x
Vega0.03x
Rho0.01x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
29.1 EUR
Average target price
37.26 EUR
Spread / Average Target
+28.03%
Consensus